Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DWER81
|
|||
| Drug Name |
ART24
|
|||
| Drug Type |
Live biotherapeutic
|
|||
| Indication | Clostridioides difficile infection [ICD-11: 1A04] | Phase 1 | [1] | |
| Company |
Artugen Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04891965) A Randomized, Placebo-Controlled, Double-Blind, Phase 1 Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.